Sign in to your account
or
By signing in you agree to our
Terms & conditions
 and 
Privacy policy
Sku Image
Sku Image
Sku Image
Sku Image
sold out tag
Genuine
Authenticity Assured
Prescription
required
Cold stored
Stored between 2-8°C
Covishield Vaccine has been approved for active immunization of individuals aged 18 years and older for the prevention of coronavirus disease 2019 (COVID-19). COVID-19 is a highly infectious disease that is caused by the coronavirus (SARS-CoV2).

Written By Dr. Lipika Khurana, PGDHHM, BDS,
Reviewed By Dr. Sachin Gupta, MD Pharmacology, MBBS,
Last updated on 25 Nov 2025 | 03:05 PM (IST)
MRP ₹0
We do not facilitate sale of this product at present
 
 
0
footer-icon

Save more with additional offers

offer icon
Pay with Amazon Pay Balance and get cashback up to Rs. 75 with minimum cashback of Rs. 15
Pay with Amazon Pay Balance and get cashback up to Rs. 75 with minimum cashback of Rs. 15
chevron icon
offer icon
Earn cashback up to Rs.75 with Amazon Pay Later
Earn cashback up to Rs.75 with Amazon Pay Later
chevron icon
offer icon
Get upto Rs.500 Cashback on minimum transaction of Rs.999/- with Mobikwik Wallet.
Get upto Rs.500 Cashback on minimum transaction of Rs.999/- with Mobikwik Wallet.
chevron icon
offer icon
Pay with Amazon Pay Balance and get cashback up to Rs. 75 with minimum cashback of Rs. 15
Pay with Amazon Pay Balance and get cashback up to Rs. 75 with minimum cashback of Rs. 15
chevron icon
offer icon
Earn cashback up to Rs.75 with Amazon Pay Later
Earn cashback up to Rs.75 with Amazon Pay Later
chevron icon
offer icon
Get upto Rs.500 Cashback on minimum transaction of Rs.999/- with Mobikwik Wallet.
Get upto Rs.500 Cashback on minimum transaction of Rs.999/- with Mobikwik Wallet.
chevron icon
offer icon
Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI.
Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI.
chevron icon
offer icon
Assured cashback up to ₹300 on minimum payment of ₹300 using Paytm UPI*
Assured cashback up to ₹300 on minimum payment of ₹300 using Paytm UPI*
chevron icon

General Information

The content is shown in English
Covishield Vaccine image
Covishield Vaccine image
Covishield Vaccine image
Covishield Vaccine image

Product introduction

Covishield Vaccine has been developed by AstraZeneca with Oxford university in the UK and is being manufactured by the Serum Institute of India (SII) in Pune. Successful clinical trials have been conducted in Sout Africa, Brazil, and the UK with bridging study results in the Indian population based on which the approval was granted by DCGI (Drugs Controller General of India).

Covishield Vaccine is given as an injection into the muscle of the upper arm. The vaccination course consists of two separate doses, given 4 to 6 weeks apart. Taking just a single dose is not enough as it is insufficient to produce a protective level of antibodies in the body to prevent the infection. So make sure you turn up for the second dose for maximum benefits.

The possible side effects of Covishield Vaccine include reactions at the site of injection (such as pain, swelling, and redness), headache, nausea, vomiting, muscle pain, joint pain, fatigue, malaise (general discomfort), fever, chills, and flu-like symptoms. Most of these side effects are mild and temporary (subside within 2-3 days) that subside on their own. If required, you may take paracetamol to provide symptomatic relief. However, if these persist (symptoms continue beyond 2-3 days) or get worse, let the doctor know. 

To make sure the vaccine is safe, before receiving the vaccine, it is important to let your doctor or vaccinator know if you have any other illnesses, history of any allergy, fever, or bleeding disorders. You should also tell the doctor about all the medicines you are taking, especially blood thinners or any medicines affecting your immune system. 

Children, pregnant women, and breastfeeding mothers have not been a part of the vaccine trials. Therefore, they should not get the vaccine at this time as the safety of the medicine for them is still not known. Also, individuals who have received another COVID-19 vaccine should not receive Covishield Vaccine.

Uses of Covishield Solution for Injection

  • Prevention of Coronavirus disease (COVID-19)

Benefits of Covishield Solution for Injection

Prevention of Coronavirus disease (COVID-19)
Covishield Vaccine is used for preventing COVID-19 infection. Moreover, even if you get infected, Covishield Vaccine may help reduce the severity of that infection. However, make sure to complete the entire dosing schedule of Covishield Vaccine. Additionally, take all the necessary precautions to ensure your safety, such as wearing a face mask, avoiding crowded places, washing your hands at regular intervals, and maintaining social distancing whenever and wherever possible.

Side effects of Covishield Solution for Injection

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Covishield
  • Injection site reactions (pain, swelling, redness)
  • Headache
  • Nausea
  • Vomiting
  • Muscle pain
  • Joint pain
  • Feeling of discomfort
  • Fever
  • Chills
  • Flu-like symptoms
  • Fatigue

How to use Covishield Solution for Injection

Your doctor or nurse will guide you how to use this medicine.

How Covishield Solution for Injection works

Covishield Vaccine contains a non-replicating virus (a weakened chimpanzee adenovirus that causes common cold), that is genetically engineered to produce coronavirus proteins in the body, but the virus is weakened and cannot cause the disease. It provides active immunization against Covid-19 infection that helps you fight the virus if exposed. This means there is a reduced risk of developing the illness and its consequences.

Quick tips

  • Covishield Vaccine is a 2-dose vaccination regimen. The second dose is administered between 4 and 6 weeks after the first dose.
  • Covishield Vaccine is usually given into the muscle (intramuscularly) of the upper arm.
  • Getting vaccinated is voluntary. However, it is advisable to complete the vaccination schedule to restrict the spread of the virus.
  • Have a proper meal before visiting the vaccination site. Do not get vaccinated on an empty stomach.
  • Individuals with confirmed or suspected COVID-19 infection should defer vaccination for 14 days after symptoms resolution as they may increase the risk of spreading the infection to others at the vaccination site.
  • A minimum interval of 14 days should be maintained between the administration of any other vaccine. However, if the benefits of vaccination outweigh the potential unknown risks of vaccine coadministration, COVID-19 and other vaccines may be administered within a shorter period (e.g., tetanus vaccine, rabies vaccine, etc.)
  • You may be observed at the vaccination center itself to guard against any immediate allergic reaction or side effect.
  • In addition to vaccination, observe other control measures such as social distancing, mask donning, and hand-washing.
  • Covishield Vaccine is currently not meant to be administered in children as safety and efficacy are not yet established.
  • Covishield Vaccine is a 2-dose vaccination regimen. The second dose is administered between 4 to 6 weeks after the first dose.
  • Covishield Vaccine is usually given into the muscle (intramuscularly) of the upper arm.
  • Getting vaccinated is voluntary. However, it is advisable to complete the vaccination schedule to restrict the spread of the virus.
  • Do get vaccinated even if you have recovered from COVID-19 infection in the past, as this will help in developing a stronger immune response.
  • Have a proper meal before visiting the vaccination site. Do not get vaccinated on an empty stomach.
  • Individuals with confirmed or suspected COVID-19 infection should defer vaccination for 14 days after symptoms resolution as they may increase the risk of spreading the infection to others at the vaccination site.
  • A minimum interval of 14 days should be maintained between the administration of any other vaccine. However, if the benefits of vaccination outweigh the potential unknown risks of vaccine coadministration, COVID-19 and other vaccines may be administered within a shorter period (e.g., tetanus vaccine, rabies vaccine, etc.)
  • You may be observed at the vaccination center itself to guard against any immediate allergic reaction or side effect.
  • In addition to vaccination, observe other control measures such as social distancing, mask donning, and hand-washing.
  • Covishield Vaccine is currently not meant to be administered in children as safety and efficacy are not yet established.

Safety advice

Alcohol

Alcohol

CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Covishield Vaccine. Please consult your doctor. As per experts, there is no evidence of alcohol impairing the effectiveness of the vaccine
Pregnancy

Pregnancy

SAFE IF PRESCRIBED
Covishield Vaccine is safe to use during pregnancy. Most studies have shown low or no risk to the developing baby.
Breast feeding

Breast feeding

SAFE IF PRESCRIBED
Available human data suggest that the drug does not pass into breast milk in clinically significant amounts and is unlikely to harm the infant.
Driving

Driving

SAFE
Covishield Vaccine does not usually affect your ability to drive.
Covishield Vaccine has no or negligible influence on the ability to drive and use machines. However, some of the adverse reactions may temporarily affect the ability to drive or use machines.
Kidney

Kidney

CONSULT YOUR DOCTOR
There is limited data available on the use of Covishield Vaccine in patients with kidney disease. Please consult your doctor.
Liver

Liver

CONSULT YOUR DOCTOR
There is limited data available on the use of Covishield Vaccine in patients with liver disease.

Frequently asked questions

Covishield Vaccine trials for children are still underway. So, enough evidence is not available to recommend its use in children yet. This is because the morbidity and mortality rate is higher in the older population, particularly those older than 50 years of age. Both the available vaccines, Covishield Vaccine as well as Covaxin have not been studied for safety and effectiveness in the children/pediatric population so far. Therefore, it is advised not to give any COVID-19 vaccine to children till we have enough data available.
As per government of India guidelines, all the COVID-19 frontline workers will get vaccinated on priority. However, the other family members of these people will be vaccinated according to the age-specific prioritization by the Government of India.
Yes. People who have already been infected with COVID-19 should still get vaccinated unless told otherwise by their healthcare provider. Even if you’ve had a previous infection, the vaccine acts as a booster that strengthens the immune response. There have also been some cases of people getting re-infected with COVID-19, which makes getting vaccinated even more important.
As per the permission granted by the Drug Controller General (India), the second dose of Covishield Vaccine is to be administered 4-12 weeks after the first dose.
Yes. All vaccines are expected to provide a reasonable amount of protection against the newer strains/mutated versions of the COVID-19 virus also. The body responds to vaccination by making more than one type of antibodies, that effectively destroy the virus. Based on the currently available data, the mutations as reported, are unlikely to make the vaccine ineffective and protect an individual against COVID-19 effectively.
There is no comparison done between the two, Covishield Vaccine or Covaxin being used in India, so one cannot say which is better. Both the vaccines are effective in preventing the COVID-19 infection in all who take it, particularly, elderly people or those who have comorbidities such as diabetes or hypertension (high blood pressure).
It usually takes 2-3 weeks after completion of the entire vaccination schedule, i.e., after the second dose of Covishield Vaccine or Covaxin, whichever has been administered to you.
Covishield Vaccine may show mild side effects like injection site tenderness or pain, headache, fatigue, myalgia (muscle pain), malaise, fever, chills, joint pain, and nausea. Very rarely, a few events of demyelinating disorders have been reported following vaccination with this vaccine but without the causal relationship establishment.
Individuals with a history of anaphylactic or allergic reaction to a previous dose of COVID-19 vaccine or any injectable therapies, pharmaceutical products, food items, etc, should not take Covishield Vaccine. Additionally, pregnant and lactating women have not been part of any COVID-19 vaccine clinical trial so far. Therefore, women who are pregnant or not sure of their pregnancy and lactating (breastfeeding) women should not receive the COVID-19 vaccine at this time. However, consult your doctor if you are not sure.
Absolutely. Covishield Vaccine is safe and effective in adults with comorbidities such as hypertension/diabetes/chronic kidney disease/heart disease/lipid disorders, etc. The maximum benefit of getting Covishield Vaccine is for those who have such comorbidities. However, if you are concerned for any specific reason, please consult your doctor.
Covishield Vaccine needs to be stored and transported at 2⁰ to 8⁰ Celsius. The cold chain for Covishield Vaccine is maintained through active and passive cold chain equipment available at approximately 29,000 cold chain points across India.
Online registration and appointment can be done through the Co-WIN portal. You will have to give some basic information about yourself and details of your photo identification card to get yourself registered online. From one mobile phone number, one can register 4 people, however, each person will need their photo identification document.
Yes. You can still get vaccinated even if you haven’t pre-registered online. Please ask your nearest Government healthcare worker to guide you about the nearest COVID-19 Vaccination Centre (CVC) where COVID vaccination will be available and the days of the week when this will be available. You need to carry your mobile phone and a photo identification document to get yourself vaccinated. The workers in the CVC will help you to register on the spot, get an appointment, and get vaccinated on the same day.
Yes. Covishield Vaccine has undergone the necessary clinical trials before granting EUA.
Emergency Use Authorization (EUA) or permission for restricted use is a declaration issued by Indian regulators in alignment with global guidelines, to use certain vaccines, medicines, or devices to diagnose, treat or prevent a serious medical condition (such as COVID-19 in the current scenario) in case there is an outbreak of such an illness that poses threat to public health. Regulatory authorities may not approve the use of any such medical measures but may still allow it to be used against the illness weighing the benefits against the risks involved. However, there are continuous lab assessments and clinical trials to check on the safety, effectiveness, and quality of the vaccines.
Five vaccines that have been granted emergency use authorization by the Drug Controller General of India (DCGI) in India are Covishield (AstraZeneca's vaccine, manufactured by Serum Institute of India), Covaxin (manufactured by Bharat Biotech Limited), Sputnik V (Russia's vaccine, being manufactured by Dr. Reddy's laboratories in India), Moderna (US vaccine being imported by Cipla, India) and the most recent being Johnson and Johnson’s single dose Covid-19 Vaccine.<br>
Coronavirus disease 2019, better known as COVID-19, is an illness of the lungs caused by a virus called SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2), which is seen to infect humans for the very first time. COVID-19 is a highly infectious viral disease that spreads from one person to another at a very fast pace. Persons suffering from COVID-19 are likely to have breathing difficulties, fever, and cough as the major symptoms.
Covishield Vaccine trials for children are still underway. So, enough evidence is not available to recommend its use in children yet. This is because the morbidity and mortality rate is higher in the older population, particularly those older than 50 years of age. Both the available vaccines, Covishield Vaccine as well as Covaxin have not been studied for safety and effectiveness in the children/pediatric population so far. Therefore, it is advised not to give any COVID-19 vaccine to children till we have enough data available.
As per government of India guidelines, all the COVID-19 frontline workers will get vaccinated on priority. However, the other family members of these people will be vaccinated according to the age-specific prioritization by the Government of India.
Yes. People who have already been infected with COVID-19 should still get vaccinated unless told otherwise by their healthcare provider. Even if you’ve had a previous infection, the vaccine acts as a booster that strengthens the immune response. There have also been some cases of people getting re-infected with COVID-19, which makes getting vaccinated even more important.
As per the permission granted by the Drug Controller General (India), the second dose of Covishield Vaccine is to be administered 12-16 weeks after the first dose. This is because, the protection offered by the vaccine increased to 79% if the second dose was given at least 12 weeks after the first dose. While it was 54% if the gap between the 2 doses which was 4-6 weeks as per initial recommendation being followed earlier. After analyzing this data, Indian government has increased the gap between both doses from 4-6 weeks to 12-16 weeks.
Yes. All vaccines are expected to provide a reasonable amount of protection against the newer strains/mutated versions of the COVID-19 virus also. The body responds to vaccination by making more than one type of antibodies, that effectively destroy the virus. Based on the currently available data, the mutations as reported, are unlikely to make the vaccine ineffective and protect an individual against COVID-19 effectively.
There is no comparison done between the two, Covishield Vaccine or Covaxin being used in India, so one cannot say which is better. Both the vaccines are effective in preventing the COVID-19 infection in all who take it, particularly, elderly people or those who have comorbidities such as diabetes or hypertension (high blood pressure).
It usually takes 2-3 weeks after completion of the entire vaccination schedule, i.e., after the second dose of Covishield Vaccine or Covaxin, whichever has been administered to you.
Covishield Vaccine may show mild side effects like injection site tenderness or pain, headache, fatigue, myalgia (muscle pain), malaise, fever, chills, joint pain, and nausea. Very rarely, a few events of demyelinating disorders have been reported following vaccination with this vaccine but without the causal relationship establishment.
Individuals with a history of anaphylactic or allergic reaction to a previous dose of COVID-19 vaccine or any injectable therapies, pharmaceutical products, food items, etc, should not take Covishield Vaccine. Additionally, pregnant and lactating women have not been part of any COVID-19 vaccine clinical trial so far. Therefore, women who are pregnant or not sure of their pregnancy and lactating (breastfeeding) women should not receive the COVID-19 vaccine at this time. However, consult your doctor if you are not sure.
Absolutely. Covishield Vaccine is safe and effective in adults with comorbidities such as hypertension/diabetes/chronic kidney disease/heart disease/lipid disorders, etc. The maximum benefit of getting Covishield Vaccine is for those who have such comorbidities. However, if you are concerned for any specific reason, please consult your doctor.
Covishield Vaccine needs to be stored and transported at 2⁰ to 8⁰ Celsius. The cold chain for Covishield Vaccine is maintained through active and passive cold chain equipment available at approximately 29,000 cold chain points across India.
Online registration and appointment can be done through the Co-WIN portal. You will have to give some basic information about yourself and details of your photo identification card to get yourself registered online. From one mobile phone number, one can register 4 people, however, each person will need their photo identification document.
Yes. You can still get vaccinated even if you haven’t pre-registered online. Please ask your nearest Government healthcare worker to guide you about the nearest COVID-19 Vaccination Centre (CVC) where COVID vaccination will be available and the days of the week when this will be available. You need to carry your mobile phone and a photo identification document to get yourself vaccinated. The workers in the CVC will help you to register on the spot, get an appointment, and get vaccinated on the same day.
Yes. Covishield Vaccine has undergone the necessary clinical trials before granting EUA.
Emergency Use Authorization (EUA) or permission for restricted use is a declaration issued by Indian regulators in alignment with global guidelines, to use certain vaccines, medicines, or devices to diagnose, treat or prevent a serious medical condition (such as COVID-19 in the current scenario) in case there is an outbreak of such an illness that poses threat to public health. Regulatory authorities may not approve the use of any such medical measures but may still allow it to be used against the illness weighing the benefits against the risks involved. However, there are continuous lab assessments and clinical trials to check on the safety, effectiveness, and quality of the vaccines.
Five vaccines that have been granted emergency use authorization by the Drug Controller General of India (DCGI) in India are Covishield (AstraZeneca's vaccine, manufactured by Serum Institute of India), Covaxin (manufactured by Bharat Biotech Limited), Sputnik V (Russia's vaccine, being manufactured by Dr. Reddy's laboratories in India), Moderna (US vaccine being imported by Cipla, India) and the most recent being Johnson and Johnson’s single dose Covid-19 Vaccine.<br>
Coronavirus disease 2019, better known as COVID-19, is an illness of the lungs caused by a virus called SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2), which is seen to infect humans for the very first time. COVID-19 is a highly infectious viral disease that spreads from one person to another at a very fast pace. Persons suffering from COVID-19 are likely to have breathing difficulties, fever, and cough as the major symptoms.

Fact Box

Chemical Class

Vaccines

Habit Forming

No

Therapeutic Class

VACCINES

References

  1. COVISHIELD [Package Insert]. Pune, Maharashtra: Serum Institute of India Pvt Ltd. [Accessed 03 Apr. 2021] (online) Available from:
  2. COVISHIELD [Fact Sheet for Vaccine Recipient]. Pune, Maharashtra: Serum Institute of India Pvt Ltd. [Accessed 03 Apr. 2021] (online) Available from:
  3. Ministry of Health and Family Welfare. Government of India. Vaccination: Frequently Asked Questions. [Accessed 03 Apr. 2021] (online) Available from:
  4. COVISHIELD [Product Monograph Including Patient Medication Information]. Mississauga, Ontario: Verity Pharmaceuticals Inc.; 2021. [Accessed 03 Apr. 2021] (online) Available from:
  5. World Health Organization. Safety of COVID-19 Vaccines. [Accessed 03 Apr. 2021] (online) Available from:
  6. World Health Organization. Getting the COVID-19 Vaccine. [Accessed 03 Apr. 2021] (online) Available from:
  7. Ministry of Health and Family Welfare. Government of India. Common Side Effects (AEFI): Some common ailments that can be expected after vaccination. [Accessed 03 Apr. 2021] (online) Available from:
  8. Ministry of Health and Family Welfare. Government of India. Questions and Answers. [Accessed 03 Apr. 2021] (online) Available from:
  9. Ministry of Health and Family Welfare. Government of India. Letter from Additional Secretary Ministry of Health and Family Welfare regarding Contraindications and Factsheet for COVID-19 vaccines [Accessed 03 Apr. 2021] (online) Available from:
  10. Hartford Healthcare. These Are the Top 5 Vaccine Questions on Google. We Have the Answers. [Accessed 04 Apr. 2021] (online) Available from:
  11. Moyer MW. When Will Kids Get COVID Vaccines? Scientific American. 2021 Mar. 30. [Accessed 04 Apr. 2021] (online) Available from:
  12. Camero K. Don’t worry if you catch coronavirus when fully vaccinated — it can happen. Here’s why. Miami Herald. 2021 Apr. 01. [Accessed 04 Apr. 2021] (online) Available from:
  13. ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant) [Pacakge Insert]. Hadapsar, Haryana: Serum Institute of India Pvt. Ltd. [Accessed 19 Oct. 2023] (online) Available from:
100% genuine products
100% genuine products
Safe & secure payments
Safe & secure payments
No contact delivery
No contact delivery
Fully sanitized facilities
Fully sanitized facilities
<h3 class=titleMediumExtraBold>Want to know more</h3>

Want to know more

We provide you with authentic, trustworthy and relevant information
<h3 class=titleMediumExtraBold>Have issue with the content</h3>

Have issue with the content

Disclaimer

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

Marketer details

Name: Serum Institute Of India Ltd
Address: 212/2, Hadapsar, Off Soli Poonawalla Road, Pune 411028 India

Vendor Details

Country of origin: India
Why we need a prescription?
Cold chain description image
close sheet